ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

TNGX Company Profile and Key Details

NASDAQ : TNGX

Tango Therapeutics, Inc.

$2.01

-0.1-4.74%

At Close 4:00 PM

$2.00

-0.01-0.50%

After-Market 03:59 PM

63.36

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

TNGX Stock Price Chart

Stock Price Today

Tango Therapeutics, Inc. (TNGX) stock declined over -4.74%, trading at $2.01 on NASDAQ, down from the previous close of $2.11. The stock opened at $2.11, fluctuating between $2.00 and $2.17 in the recent session.

Stock Snapshot

2.11

Prev. Close

2.11

Open

217.3M

Market Cap

108.11M

Number of Shares

Day Low

2.17

Day High

-1.69

P/E Ratio

54.69%

Free Float in %

-1.19

EPS (TTM)

2.6

Book Value

-1.23

Cash Flow per Share

639.15K

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Mar 07, 2025	2.11	2.17	2.00	2.01	646.52K
Mar 06, 2025	2.04	2.17	2.00	2.11	570.71K
Mar 05, 2025	1.84	2.13	1.81	2.09	984.37K
Mar 04, 2025	1.85	1.90	1.78	1.84	1.15M
Mar 03, 2025	2.12	2.21	1.81	1.90	1.29M
Feb 28, 2025	2.17	2.17	1.97	2.07	2.69M
Feb 27, 2025	2.33	2.39	2.17	2.18	600.9K
Feb 26, 2025	2.29	2.44	2.23	2.33	541.3K
Feb 25, 2025	2.36	2.39	2.23	2.30	418.48K
Feb 24, 2025	2.36	2.38	2.26	2.35	561.06K
Feb 21, 2025	2.45	2.50	2.35	2.36	547.26K
Feb 20, 2025	2.43	2.51	2.41	2.43	597.1K
Feb 19, 2025	2.38	2.47	2.35	2.41	446.82K
Feb 18, 2025	2.46	2.62	2.42	2.44	638.09K
Feb 14, 2025	2.54	2.70	2.45	2.47	662.42K
Feb 13, 2025	2.46	2.62	2.44	2.51	795.2K
Feb 12, 2025	2.45	2.54	2.41	2.46	685.8K
Feb 11, 2025	2.69	2.69	2.47	2.49	1.04M
Feb 10, 2025	3.06	3.06	2.72	2.73	616.33K
Feb 07, 2025	3.23	3.28	3.03	3.03	424.22K

Contact Details

Cambridge, MA 02142

United States

Website: https://www.tangotx.comContact: 857 320 4900

About Company

Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops Ubiquitin-specific protease 1, an inhibitor to treat patients with BRCA1 or BRCA2-mutant cancers; and Target 3 for STK11-mutant cancers. Tango Therapeutics, Inc. has a strategic collaboration with Gilead Sciences, Inc. for the discovery, development, and commercialization of a pipeline of therapies for patients with cancer. The company was founded in 2017 and is based in Cambridge, Massachusetts.

Frequently Asked Questions

What is the current Tango Therapeutics, Inc. (TNGX) stock price?

Tango Therapeutics, Inc. (NASDAQ: TNGX) stock price is $2.01 in the last trading session. During the trading session, TNGX stock reached the peak price of $2.17 while $2.00 was the lowest point it dropped to. The percentage change in TNGX stock occurred in the recent session was -4.74% while the dollar amount for the price change in TNGX stock was -$0.10.

TNGX's industry and sector of operation?

The NASDAQ listed TNGX is part of Biotechnology industry that operates in the broader Healthcare sector. Tango Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of TNGX?

Dr. Antoni Ribas M.D., Ph.D.
Founder & Member of Scientific Advisory Board
Dr. Barbara L. Weber M.D.
Pres, Chief Executive Officer & Director
Ms. Daniella Beckman CPA
Chief Financial Officer
Dr. Alan Huang Ph.D.
Chief Scientific Officer
Dr. Levi Garraway M.D., Ph.D.
Founder
Mr. Douglas J. Barry Esq., J.D.
Gen. Counsel, Chief Compliance Officer & Corporation Sec.
Mr. John C. Ross M.S.
Vice President of HR
Dr. William G. Kaelin Jr., M.D.
Founder & Member of Scientific Advisory Board
Dr. Alan Ashworth FRS, Ph.D.
Founder & Member of Scientific Advisory Board

How TNGX did perform over past 52-week?

TNGX's closing price is 12.92% higher than its 52-week low of $1.78 where as its distance from 52-week high of $12.02 is -83.27%.

How many employees does TNGX have?

Number of TNGX employees currently stands at 155.

Link for TNGX official website?

Official Website of TNGX is: https://www.tangotx.com

How do I contact TNGX?

TNGX could be contacted at phone 857 320 4900 and can also be accessed through its website. TNGX operates from 100 Binney Street, Cambridge, MA 02142, United States.

How many shares of TNGX are traded daily?

TNGX stock volume for the day was 639.15K shares. The average number of TNGX shares traded daily for last 3 months was 962.98K.

What is the market cap of TNGX currently?

The market value of TNGX currently stands at $217.30M with its latest stock price at $2.01 and 108.11M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

Employees	155
Beta	0.87
Sales or Revenue	$36.53M
5Y Sales Change%	-0.859%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology